| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/03/2011 | CA2779381A1 Marker protein for type 2 diabetes |
| 06/03/2011 | CA2778714A1 Targeted binding agents against b7-h1 |
| 06/03/2011 | CA2776513A1 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume |
| 06/02/2011 | US20110131671 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 06/02/2011 | US20110131670 Non-Aggregating Fluorescent Proteins and Methods for Using the Same |
| 06/02/2011 | US20110131029 Crystal structure of the influenza virus polymerase pac-pb1n complex and uses thereof |
| 06/02/2011 | US20110130549 Method for the treatment of amyloidoses |
| 06/02/2011 | US20110130548 Anti-human il-21 monoclonal antibodies |
| 06/02/2011 | US20110130547 Reagents For The Detection Of Protein Phosphorylation In EGFR Signaling Pathways |
| 06/02/2011 | US20110130546 Immunosuppressive polypeptides and nucleic acids |
| 06/02/2011 | US20110130545 Process for producing milk fractions rich in secretory immunoglobulins |
| 06/02/2011 | US20110130544 Antibodies with decreased deamidation profiles |
| 06/02/2011 | US20110130335 Therapeutic agent and test agent for disease with myocardial necrosis |
| 06/02/2011 | US20110130328 Flavivirus fusion inhibitors |
| 06/02/2011 | US20110130324 Methods for systematic control of protein stability |
| 06/02/2011 | US20110130306 Pro-fluorescent probes |
| 06/02/2011 | US20110130305 Novel dyes and compositions, and processes for using same in analysis of protein aggregation and other applications |
| 06/02/2011 | US20110129916 Monoclonal antibodies with specificity for fetal erythroid cells |
| 06/02/2011 | US20110129859 Biomarker for diagnosis of liver disease |
| 06/02/2011 | US20110129857 Methods Of Detecting Or Monitoring Activity Of An Inflammatory Condition Or Neurodegenerative Condition |
| 06/02/2011 | US20110129855 Recombinant Anti-Epidermal Growth Factor Receptor Antibody Compositions |
| 06/02/2011 | US20110129848 Antibody Recognizing G Protein, and Agent and Kit Using the Same |
| 06/02/2011 | US20110129842 Cyanobacteria saxitoxin gene cluster and detection of cyanotoxic organisms |
| 06/02/2011 | US20110129831 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
| 06/02/2011 | US20110129819 Diagnosis of hereditary spastic paraplegias (hsp) by indentification of a mutation in the kiaa1840 gene or protein |
| 06/02/2011 | US20110129816 Device for detection of influenza virus |
| 06/02/2011 | US20110129525 Mucosal membrane receptor and uses thereof |
| 06/02/2011 | US20110129500 Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel lawsonia intracellularis serotype and hybridomas for producing the said antibodies |
| 06/02/2011 | US20110129488 Immunotherapy compositions for the treatment and prevention of amyloidosis |
| 06/02/2011 | US20110129485 Modified Galectin-2 and Uses Thereof |
| 06/02/2011 | US20110129483 Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy |
| 06/02/2011 | US20110129482 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 06/02/2011 | US20110129481 Antibody specifically binding to c-Met and methods of use |
| 06/02/2011 | US20110129480 Anti-ferroportin 1 monoclonal antibodies and uses thereof |
| 06/02/2011 | US20110129478 Pharmaceutical composition for treatment and prevention of cancer |
| 06/02/2011 | US20110129477 NOGO Receptor Homologs |
| 06/02/2011 | US20110129476 Mzb1, a novel b cell factor, and uses thereof |
| 06/02/2011 | US20110129475 Basb 205 polypeptides and polynucleotides from haemophilus influenzae |
| 06/02/2011 | US20110129473 Vhnar anti-cytokine domains |
| 06/02/2011 | US20110129471 Chronic lymphocytic leukemia cell line |
| 06/02/2011 | US20110129468 Purified immunoglobulin fusion proteins and methods of their purification |
| 06/02/2011 | US20110129466 Methods of treating cancer by administering antibodies to cd200 |
| 06/02/2011 | US20110129465 Mammalian Receptor Proteins; Related Reagents and Methods |
| 06/02/2011 | US20110129464 Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies |
| 06/02/2011 | US20110129459 Anti-nr10 antibody and use thereof |
| 06/02/2011 | US20110129458 Binding molecules with multiple binding sites, compositions comprising the same and uses thereof |
| 06/02/2011 | US20110129457 Variant hhip1 protein and methods and uses thereof |
| 06/02/2011 | US20110129441 Method and system to remove soluble tnfr1, tnfr2, and il2 in patients |
| 06/02/2011 | US20110129416 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 06/02/2011 | US20110129415 Novel antibody and use in diagnosis and therapy of arthropathies |
| 06/02/2011 | US20110129414 Single Chain Fragment of Monoclonal Antibody 9B9 and Uses Thereof |
| 06/02/2011 | US20110129413 Bioconjugation of Calcium Phosphosilicate Nanoparticles For Selective Targeting of Cells In Vivo |
| 06/02/2011 | US20110129412 Antibodies Directed to CD20 and Uses Thereof |
| 06/01/2011 | EP2327778A1 Nucleic acid occurring in blood from hepatitis patient, polypeptide encoded by the nucleic acid, and use of the same |
| 06/01/2011 | EP2327767A1 Nitrilases |
| 06/01/2011 | EP2327766A1 Nitrilases |
| 06/01/2011 | EP2327765A1 Nitrilases |
| 06/01/2011 | EP2327726A2 Human monoclonal antibodies against human il-4 |
| 06/01/2011 | EP2327725A1 Anti-C5a binding moieties with high blocking activity |
| 06/01/2011 | EP2327721A2 Genetic products which are differentially expressed in tumours and use thereof |
| 06/01/2011 | EP2327720A1 Enterococcus antigens |
| 06/01/2011 | EP2327718A1 Improved expression systems with SEC-system secretion |
| 06/01/2011 | EP2327717A1 Replikin peptides and uses thereof |
| 06/01/2011 | EP2327716A1 Replikin peptides and uses thereof |
| 06/01/2011 | EP2327715A1 Replikin peptides and uses thereof |
| 06/01/2011 | EP2327712A2 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 06/01/2011 | EP2327705A1 Podophyllotoxins as antiproliferative agents |
| 06/01/2011 | EP2327451A2 Method for detecting and inhibiting angiogenesis |
| 06/01/2011 | EP2327423A2 Human antibodies against human interleukin-22 (IL-22) |
| 06/01/2011 | EP2327422A1 Activin antagonists for diagnosis and therapy of diseases associated with fibrosis |
| 06/01/2011 | EP2327421A1 Stabilized liquid anti-RSV antibody formulations |
| 06/01/2011 | EP2327418A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from other viruses |
| 06/01/2011 | EP2326669A2 Pta072 protein |
| 06/01/2011 | EP2326668A1 Anti-il-12/il-23 antibodies |
| 06/01/2011 | EP2326347A2 Targeting pathogenic monocytes |
| 06/01/2011 | EP2326346A1 Dock-and-lock (dnl) vaccines for cancer therapy |
| 06/01/2011 | EP2118668B1 Method of determining equine nt-probnp. |
| 06/01/2011 | EP2015775B1 Combination of an anti edb fibronectin domain antibody l19-sip and an anti-egfr antibody |
| 06/01/2011 | EP1876445B1 Antibody directed against gastrin-releasing peptide precursor and use thereof |
| 06/01/2011 | EP1608307B1 An antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same |
| 06/01/2011 | EP1354946B1 Bhlh-pas proteins, genes thereof and utilization of the same |
| 06/01/2011 | CN1982338B Neutralized monoclone antibody 4C13 of antiricin, its production and use |
| 06/01/2011 | CN1805755B Therapeutic use of anti- CS1 antibodies |
| 06/01/2011 | CN102084249A Antibody directed against pro-gastrin releasing peptide, and use thereof |
| 06/01/2011 | CN102083984A Cynomolgus toll-like receptor 3 |
| 06/01/2011 | CN102083861A Cancer treatment using humanized antibodies that bind to EphB4 |
| 06/01/2011 | CN102083860A Antibodies to IL-6 and their uses |
| 06/01/2011 | CN102083859A Humanized antibodies against human interferon-alpha |
| 06/01/2011 | CN102083858A Anti-IL 17A/IL-17F cross-reactive antibodies and methods of use thereof |
| 06/01/2011 | CN102083853A Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 06/01/2011 | CN102083464A Cytotoxic immunoglobulin |
| 06/01/2011 | CN102081093A Hepatitis C virus as well as kit of surface antigen and detection method thereof |
| 06/01/2011 | CN102080067A Method for detecting deoxynivalenol and special reagent kit thereof |
| 06/01/2011 | CN102080066A Method for detecting T-2 toxin and special reagent kit thereof |
| 06/01/2011 | CN102079789A Method for detecting maduramicin and special enzyme-linked immunoassay reagent kit thereof |
| 06/01/2011 | CN102079788A Method for detecting sulfanilamide medicine and special enzyme-linked immunoassay reagent kit thereof |
| 06/01/2011 | CN102079787A Antihuman CD52 engineering antibody, carrier, kit and application thereof |
| 06/01/2011 | CN102079786A Synthesizing method of complete antigen of enramycin |
| 06/01/2011 | CN102079783A Japanese blood fluke protein and application thereof |
| 06/01/2011 | CN102079728A Tripolycyanamide analogue, preparation method of tripolycyanamide analogue and intermediate used in preparation method |